Multimodal Prehabilitation for Lung Cancer Surgery
(MMP-LUNG Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores ways to improve recovery for people with lung cancer after surgery. It tests whether a special treatment plan, including exercise and a nutrient supplement, or just the supplement alone, enhances recovery and physical ability. The trial seeks participants undergoing lung cancer surgery who have nutritional needs and can walk independently. Those in this situation may find this trial beneficial. As an unphased trial, it offers a unique opportunity to contribute to innovative recovery strategies for lung cancer patients.
Will I have to stop taking my current medications?
You may need to stop taking omega-3 supplements during the study. If you are taking vitamin D, you can continue unless your vitamin D levels are too high. The protocol does not specify other medications.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that both multimodal prehabilitation and mixed-nutrient supplement treatments are generally safe for participants. In a study with lung cancer patients, multimodal prehabilitation—which includes exercise, nutritional support, and relaxation techniques—reduced complications after surgery, indicating good patient tolerance.
For the mixed-nutrient supplement, studies found it was well accepted by patients awaiting lung cancer surgery. This supplement contains whey protein, vitamin D, and omega-3 fatty acids, which are common in many diets. Both treatments have proven practical and safe for similar groups of people.12345Why are researchers excited about this trial?
Researchers are excited about these treatments for lung cancer surgery because they offer a new way to prepare patients for the procedure. The multimodal prehabilitation approach combines structured exercise, nutritional optimization, and relaxation strategies, which is a unique blend compared to standard care that mainly focuses on post-surgery recovery. The mixed-nutrient supplement is packed with whey protein, leucine, vitamin D, and omega-3 fatty acids, which are not typically emphasized in current pre-surgery protocols. These interventions aim to boost patients' strength and resilience before surgery, potentially leading to better outcomes and faster recovery times.
What evidence suggests that this trial's treatments could be effective for lung cancer surgery patients?
This trial will compare different approaches to prehabilitation for lung cancer surgery. Studies have shown that a combination of exercises and other preparations before surgery, provided to participants in the multimodal intervention (MM) arm, can greatly reduce complications. This approach improves physical activity, as demonstrated by longer distances walked in six minutes. Research also shows that this method leads to better overall recovery and fewer problems after surgery.
Participants in another arm will receive a mixed-nutrient supplement (NUT). Early findings suggest it may help improve muscle health in lung cancer patients. This is important because poor nutrition can cause more complications and longer hospital stays. The supplement, which includes ingredients like protein and omega-3s, is designed to support better surgical outcomes.12367Who Is on the Research Team?
Stéphanie Chevalier, PhD
Principal Investigator
McGill University
Are You a Good Fit for This Trial?
This trial is for adults over 45 with early-stage lung cancer (NSCLC stages I, II or IIIa) who are at nutritional risk and scheduled for specific types of lung surgery. They must be able to exercise and not already taking certain supplements. People with severe kidney issues, recent chemo or radiotherapy, allergies to milk/seafood, or language barriers can't join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Prehabilitation
Participants receive a multimodal prehabilitation intervention including a mixed-nutrient supplement and structured exercise training for 4 weeks prior to surgery
Postoperative Intervention
Participants continue the intervention with a focus on recovery, including the same multimodal approach for 6 weeks after hospital discharge
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Mixed-nutrient supplement (NUT)
- Multimodal Prehabilitation (MM)
- Placebo Control (CTRL)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Stéphanie Chevalier
Lead Sponsor
Canadian Institutes of Health Research (CIHR)
Collaborator